Search Within

Evelina Pogoriler

Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Department of Medicine (5)
  2. GSK Faculty (5)
  3. Melanoma and Immunotherapeutics Service (5)
  4. Solid Tumor Oncology Division (5)
  5. Advanced Practice Providers (3)
  6. Biostatistics Service (3)

More Groups

People
  1. Jedd Wolchok (5)
  2. Jianda Yuan (5)
  3. James Allison (4)
  4. Yinyan Xu (4)
  5. Arvin Yang (3)
  6. Brian Ginsberg (3)

More People

Years
  1. 2011 (2)
  2. 2010 (2)
  3. 2008 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Proceedings of the National Academy of Sciences of the United States of America (2)
  3. Journal of Immunotherapy (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. National Academy of Sciences (2)
  3. Lippincott Williams & Wilkins (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis
    Meeting Abstract

    Callahan, M. K.; Yang, A.; Tandon, S.; Xu, Y.; Subudhi, S. K.; Roman, R. A.; Heine, A. I.; Pogoriler, E.; Kuk, D.; Panageas, K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
    Journal Article

    Yuan, J.; Adamow, M.; Ginsberg, B. A.; Rasalan, T. S.; Ritter, E.; Gallardo, H. F.; Xu, Y.; Pogoriler, E.; Terzulli, S. L.; Kuk, D.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2011)

    Fulltext@MSK | Save
  • CTLA-4 blockade with ipilimumab increases peripheral CD8+ T cells: Correlation with clinical outcomes
    Meeting Abstract

    Yang, A.; Kendle, R. F.; Ginsberg, B. A.; Roman, R.; Heine, A. I.; Pogoriler, E.; Yuan, J. D.; Wolchok, J. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • NY-ESO-1-specific CD8 T cell response in NY-ESO-1 seropositive metastatic melanoma patients treated with ipilimumab correlates with clinical benefit
    Meeting Abstract

    Yuan, J. D.; Gnjatic, S.; Adamow, M.; Ginsberg, B.; Rasalan, T. S.; Ritter, E.; Gallardo, H. F.; Xu, Y.; Pogoriler, E.; Panageas, K. S.; more...
    Journal of Immunotherapy (2010)

    Fulltext@MSK | Save
  • CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
    Journal Article

    Yuan, J.; Gnjatic, S.; Li, H.; Powel, S.; Gallardo, H. F.; Ritter, E.; Ku, G. Y.; Jungbluth, A. A.; Segal, N. H.; Rasalan, T. S.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2008)

    Fulltext@MSK | Save